ZIPRASIDONE HCL

ZIPRASIDONE HCL was reported 2660 times

ZIPRASIDONE HCL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BLOOD PROLACTIN ABNORMAL 370 0.4287
1 ANOSOGNOSIA 324 0.4219
2 PERSONALITY CHANGE DUE TO A GENERAL MEDICAL CONDITION 22 0.1760
3 ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC 111 0.1606
4 DISTURBANCE IN SOCIAL BEHAVIOUR 315 0.1336
5 ORTHOSTATIC HYPERTENSION 69 0.1184
6 SYDENHAM'S CHOREA 2 0.1111
7 CARDIOMETABOLIC SYNDROME 10 0.1053
8 PHARYNGEAL DYSTONIA 2 0.0909
9 SCHIZOPHRENIA, CATATONIC TYPE 2 0.0769
10 TESTICULAR OPERATION 4 0.0714
11 DISINHIBITION 109 0.0677
12 FEMINISATION ACQUIRED 3 0.0588
13 METABOLIC DISORDER 340 0.0585
14 RABBIT SYNDROME 8 0.0482
15 METABOLIC SYNDROME 61 0.0371
16 HOMOSEXUALITY 2 0.0328
17 SEXUAL DYSFUNCTION 384 0.0327
18 PERSONALITY CHANGE 296 0.0318
19 THERAPEUTIC PRODUCT EFFECT VARIABLE 104 0.0268
20 SCHIZOAFFECTIVE DISORDER 46 0.0258
21 GENDER DYSPHORIA 2 0.0227
22 DYSLIPIDAEMIA 115 0.0226
23 DYSTONIA 388 0.0200
24 HYPERINSULINISM 2 0.0187
25 OCULOGYRIC CRISIS 38 0.0177
26 TOURETTE'S DISORDER 4 0.0176
27 IMPULSE-CONTROL DISORDER 34 0.0165
28 NIPPLE SWELLING 4 0.0159
29 SEDATION 405 0.0154
30 SCHIZOPHRENIA 187 0.0154
31 OBSESSIVE-COMPULSIVE DISORDER 123 0.0153
32 PARANOID PERSONALITY DISORDER 2 0.0152
33 OSTEOSYNTHESIS 2 0.0149
34 HYPEROSMOLAR HYPERGLYCAEMIC STATE 2 0.0143
35 BEHCET'S SYNDROME 2 0.0141
36 AKATHISIA 180 0.0132
37 FEMALE SEXUAL DYSFUNCTION 3 0.0132
38 MASKED FACIES 5 0.0123
39 POSTURE ABNORMAL 38 0.0117
40 MALIGNANT CATATONIA 3 0.0114
41 EUPHORIC MOOD 115 0.0112
42 STREPTOCOCCAL URINARY TRACT INFECTION 2 0.0104
43 ALCOHOLIC 2 0.0101
44 SPASMODIC DYSPHONIA 3 0.0099
45 DYSKINESIA 393 0.0097
46 POSTURING 5 0.0096
47 RESPIRATORY MUSCLE WEAKNESS 3 0.0093
48 AMIMIA 1 0.0091
49 SCHIZOAFFECTIVE DISORDER BIPOLAR TYPE 2 0.0087
50 SPERM CONCENTRATION DECREASED 3 0.0087
51 HYPOGONADISM MALE 2 0.0086
52 PARKINSONISM 82 0.0084
53 GRANDIOSITY 3 0.0082
54 MYOGLOBIN URINE PRESENT 2 0.0081
55 LEUKAEMIA 76 0.0080
56 OBESITY 128 0.0080
57 CORNEAL REFLEX DECREASED 3 0.0080
58 ACETONAEMIA 2 0.0079
59 SUICIDE ATTEMPT 474 0.0078
60 PLEUROTHOTONUS 7 0.0077
61 VICTIM OF ABUSE 2 0.0074
62 HAEMORRHAGIC OVARIAN CYST 4 0.0070
63 ASPIRATION BRONCHIAL 2 0.0068
64 PERSONALITY DISORDER 17 0.0065
65 MYOPATHY TOXIC 4 0.0065
66 SLEEP ATTACKS 3 0.0063
67 INCREASED APPETITE 118 0.0062
68 PRESSURE OF SPEECH 4 0.0062
69 NEONATAL RESPIRATORY DEPRESSION 2 0.0060
70 BLOOD PROLACTIN INCREASED 28 0.0059
71 BLOOD OESTROGEN ABNORMAL 1 0.0058
72 ACTIVATION SYNDROME 2 0.0058
73 ATHETOSIS 1 0.0057
74 RADIAL NERVE PALSY 2 0.0057
75 GLASGOW COMA SCALE ABNORMAL 2 0.0055
76 ABULIA 5 0.0054
77 ACANTHOSIS NIGRICANS 1 0.0054
78 INSURANCE ISSUE 80 0.0052
79 NEUROLEPTIC MALIGNANT SYNDROME 60 0.0051
80 DEATH OF RELATIVE 2 0.0049
81 THERAPY REGIMEN CHANGED 2 0.0049
82 DIABETES MELLITUS NON-INSULIN-DEPENDENT 7 0.0048
83 DEPERSONALISATION 4 0.0048
84 ANOXIC ENCEPHALOPATHY 3 0.0047
85 DIABETIC COMA 13 0.0046
86 ELEVATED MOOD 2 0.0046
87 HALLUCINATION, TACTILE 3 0.0045
88 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 5 0.0045
89 CARDIAC HYPERTROPHY 5 0.0045
90 GLYCOSURIA 6 0.0044
91 SUBSTANCE ABUSE 34 0.0042
92 VERBAL ABUSE 2 0.0041
93 BLUNTED AFFECT 3 0.0041
94 DIABETES MELLITUS INSULIN-DEPENDENT 2 0.0040
95 TESTICULAR SWELLING 5 0.0039
96 PO2 INCREASED 2 0.0039
97 BRUGADA SYNDROME 4 0.0039
98 ELECTROCARDIOGRAM QT CORRECTED INTERVAL PROLONGED 3 0.0038
99 PRESCRIBED OVERDOSE 71 0.0037
100 BURNOUT SYNDROME 2 0.0035
101 BLOOD CHOLESTEROL ABNORMAL 16 0.0035
102 SYMPTOM RECURRENCE 20 0.0033
103 PUPILLARY REFLEX IMPAIRED 6 0.0032
104 BUNDLE BRANCH BLOCK 3 0.0032
105 RESTING TREMOR 2 0.0031
106 REFLEXES ABNORMAL 2 0.0031
107 FALSE POSITIVE INVESTIGATION RESULT 3 0.0030
108 COGWHEEL RIGIDITY 3 0.0029
109 FOETAL HEART RATE DECELERATION ABNORMALITY 2 0.0028
110 PCO2 INCREASED 2 0.0028
111 CARDIAC ENZYMES INCREASED 2 0.0028
112 COMPLETED SUICIDE 231 0.0028
113 SLEEP PARALYSIS 4 0.0027
114 HALLUCINATION, AUDITORY 43 0.0027
115 CATATONIA 14 0.0027
116 GALACTORRHOEA 17 0.0026
117 NEGATIVISM 2 0.0026
118 GRANULOCYTOPENIA 15 0.0026
119 INFARCTION 18 0.0026
120 CEREBRAL VENTRICLE DILATATION 3 0.0026
121 BLOOD SODIUM INCREASED 7 0.0026
122 HOMICIDAL IDEATION 10 0.0025
123 MEAN CELL HAEMOGLOBIN INCREASED 4 0.0024
124 MICROCEPHALY 3 0.0023
125 SOLILOQUY 2 0.0023
126 HYPERPROLACTINAEMIA 15 0.0023
127 TESTICULAR ATROPHY 2 0.0023
128 ANAEMIA MEGALOBLASTIC 1 0.0022
129 BANKRUPTCY 1 0.0022
130 MULTIPLE DRUG OVERDOSE INTENTIONAL 7 0.0022
131 HALLUCINATIONS, MIXED 9 0.0021
132 CULTURE URINE POSITIVE 3 0.0021
133 ANTIPSYCHOTIC DRUG LEVEL INCREASED 6 0.0021
134 PENILE SIZE REDUCED 2 0.0021
135 PSYCHOTIC DISORDER 62 0.0021
136 INTUSSUSCEPTION 2 0.0021
137 VAGINAL DISORDER 2 0.0021
138 INFUSION SITE NODULE 2 0.0021
139 JUDGEMENT IMPAIRED 3 0.0021
140 CONVERSION DISORDER 4 0.0021
141 DELUSION 32 0.0021
142 EXTRAPYRAMIDAL DISORDER 51 0.0021
143 OVERWEIGHT 11 0.0020
144 RESPIRATORY ARREST 56 0.0020
145 TACHYPHRENIA 7 0.0020
146 LEUKOPENIA 101 0.0020
147 MANIA 33 0.0020
148 LOGORRHOEA 7 0.0020
149 PARANOIA 34 0.0020
150 PSYCHOTIC BEHAVIOUR 2 0.0020
151 ALVEOLITIS ALLERGIC 2 0.0019
152 DIABETES MELLITUS 147 0.0019
153 CONSCIOUSNESS FLUCTUATING 2 0.0019
154 HYPOMANIA 7 0.0019
155 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 2 0.0019
156 AUTOSCOPY 1 0.0019
157 ELECTROCARDIOGRAM QT PROLONGED 66 0.0018
158 MULTIPLE DRUG OVERDOSE 9 0.0018
159 TORSADE DE POINTES 14 0.0018
160 APNOEIC ATTACK 1 0.0018
161 POLYDIPSIA 7 0.0018
162 HALO VISION 2 0.0018
163 PRE-EXISTING CONDITION IMPROVED 11 0.0018
164 BLOOD PH DECREASED 3 0.0018
165 BLOOD TRIGLYCERIDES INCREASED 31 0.0018
166 BLOOD GLUCOSE INCREASED 329 0.0017
167 PO2 DECREASED 2 0.0017
168 PRIAPISM 6 0.0017
169 ENURESIS 7 0.0017
170 PUPIL FIXED 3 0.0017
171 HAEMORRHAGIC DIATHESIS 6 0.0017
172 OBSESSIVE THOUGHTS 3 0.0017
173 DIABETES INSIPIDUS 4 0.0017
174 BIPOLAR DISORDER 18 0.0017
175 STARING 4 0.0017
176 DRUG TOXICITY 22 0.0016
177 HYPERTENSIVE HEART DISEASE 3 0.0016
178 HEPATIC NECROSIS 6 0.0016
179 BLOOD BICARBONATE DECREASED 3 0.0016
180 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 111 0.0016
181 PSYCHIATRIC DECOMPENSATION 3 0.0015
182 FEELINGS OF WORTHLESSNESS 2 0.0015
183 BREAST ENLARGEMENT 5 0.0015
184 PERFORMANCE STATUS DECREASED 7 0.0015
185 THERAPEUTIC AGENT TOXICITY 5 0.0015
186 TYPE 1 DIABETES MELLITUS 9 0.0015
187 BODY MASS INDEX INCREASED 2 0.0015
188 GESTATIONAL DIABETES 7 0.0015
189 THYROID NEOPLASM 4 0.0014
190 IMPAIRED SELF-CARE 3 0.0014
191 HYPOSPADIAS 3 0.0014
192 INSULIN RESISTANCE 3 0.0014
193 MAST CELL ACTIVATION SYNDROME 2 0.0014
194 ADVERSE DRUG REACTION 128 0.0014
195 TORTICOLLIS 3 0.0014
196 BORDERLINE PERSONALITY DISORDER 1 0.0014
197 SEROTONIN SYNDROME 27 0.0014
198 PORPHYRIA ACUTE 2 0.0014
199 DEREALISATION 3 0.0014
200 BITE 1 0.0014
201 DYSPHORIA 7 0.0014
202 NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL 2 0.0014
203 ACCOMMODATION DISORDER 1 0.0014
204 BIPOLAR I DISORDER 3 0.0014
205 AORTIC VALVE SCLEROSIS 1 0.0014
206 GENERALISED ANXIETY DISORDER 2 0.0014
207 POISONING 17 0.0014
208 INFERTILITY 2 0.0013
209 AGE-RELATED MACULAR DEGENERATION 2 0.0013
210 READING DISORDER 3 0.0013
211 DRUG LEVEL ABOVE THERAPEUTIC 6 0.0013
212 THINKING ABNORMAL 24 0.0013
213 ELECTROCARDIOGRAM T WAVE ABNORMAL 2 0.0013
214 DYSMORPHISM 3 0.0013
215 TESTICULAR PAIN 4 0.0013
216 ANTICHOLINERGIC SYNDROME 2 0.0013
217 WEIGHT INCREASED 280 0.0012
218 IRRITABILITY 75 0.0012
219 INTRA-UTERINE DEATH 2 0.0012
220 SINUS BRADYCARDIA 12 0.0012
221 HYPOVENTILATION 4 0.0012
222 PITUITARY TUMOUR BENIGN 2 0.0012
223 ALTERED VISUAL DEPTH PERCEPTION 1 0.0012
224 CEREBRAL DISORDER 9 0.0012
225 SUICIDAL IDEATION 111 0.0012
226 ACCIDENTAL NEEDLE STICK 1 0.0012
227 AGITATION 88 0.0012
228 SELF-INJURIOUS IDEATION 5 0.0012
229 EXPOSURE VIA INGESTION 3 0.0012
230 AGGRESSION 59 0.0012
231 DIABETIC COMPLICATION 3 0.0012
232 ENTERITIS INFECTIOUS 2 0.0012
233 GAZE PALSY 2 0.0012
234 APTYALISM 1 0.0012
235 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 6 0.0012
236 MUSCLE CONTRACTIONS INVOLUNTARY 4 0.0011
237 FOOD INTERACTION 2 0.0011
238 ALCOHOL ABUSE 3 0.0011
239 CLONUS 3 0.0011
240 MENTAL STATUS CHANGES 30 0.0011
241 ARTHRITIS INFECTIVE 5 0.0011
242 BLOOD CREATINE PHOSPHOKINASE INCREASED 31 0.0011
243 ACCIDENTAL DEATH 2 0.0011
244 BLOOD CHOLESTEROL DECREASED 2 0.0011
245 COGNITIVE DISORDER 50 0.0011
246 SNORING 4 0.0011
247 CONDITION AGGRAVATED 319 0.0010
248 AGITATION NEONATAL 1 0.0010
249 DIABETIC KETOACIDOSIS 25 0.0010
250 HUMERUS FRACTURE 5 0.0010
251 SKIN WARM 6 0.0010
252 OCULAR HYPERTENSION 2 0.0010
253 CUTANEOUS LUPUS ERYTHEMATOSUS 2 0.0010
254 BRADYKINESIA 6 0.0010
255 PNEUMONIA STAPHYLOCOCCAL 2 0.0010
256 DIABETIC NEUROPATHY 5 0.0010
257 GASTROINTESTINAL SOUNDS ABNORMAL 5 0.0010
258 MUSCLE RIGIDITY 12 0.0010
259 ANTISOCIAL BEHAVIOUR 1 0.0010
260 TARDIVE DYSKINESIA 28 0.0010
261 AUTONOMIC NEUROPATHY 1 0.0010
262 LIBIDO INCREASED 2 0.0010
263 TOXICITY TO VARIOUS AGENTS 166 0.0010
264 SELF INJURIOUS BEHAVIOUR 3 0.0010
265 CHEST INJURY 2 0.0010
266 PHYSICAL ASSAULT 2 0.0010
267 BLEPHAROSPASM 6 0.0010
268 ASTERIXIS 1 0.0009
269 ABNORMAL BEHAVIOUR 37 0.0009
270 ATRIOVENTRICULAR BLOCK FIRST DEGREE 4 0.0009
271 HYPERTHERMIA 7 0.0009
272 TIC 5 0.0009
273 SUSPECTED COVID-19 3 0.0009
274 DIABETIC NEPHROPATHY 2 0.0009
275 APPETITE DISORDER 6 0.0009
276 HIGH DENSITY LIPOPROTEIN DECREASED 3 0.0009
277 SALIVARY HYPERSECRETION 9 0.0009
278 CALCINOSIS 2 0.0009
279 DRUG LEVEL DECREASED 9 0.0009
280 DISTRIBUTIVE SHOCK 2 0.0009
281 BLOODY DISCHARGE 1 0.0009
282 REACTION TO EXCIPIENT 2 0.0009
283 AORTIC THROMBOSIS 1 0.0009
284 SOCIAL AVOIDANT BEHAVIOUR 5 0.0009
285 FLAT AFFECT 2 0.0009
286 HYPERREFLEXIA 3 0.0009
287 MENTAL DISORDER 37 0.0008
288 GLUCOSE TOLERANCE IMPAIRED 5 0.0008
289 MYOPIA 2 0.0008
290 LACUNAR INFARCTION 2 0.0008
291 BILE DUCT STENOSIS 1 0.0008
292 HYPERCHOLESTEROLAEMIA 8 0.0008
293 ORAL INTAKE REDUCED 2 0.0008
294 MAJOR DEPRESSION 6 0.0008
295 MUSCLE SPASTICITY 10 0.0008
296 CARDIO-RESPIRATORY ARREST 34 0.0008
297 ACUTE PSYCHOSIS 2 0.0008
298 SMALL FOR DATES BABY 4 0.0008
299 PERSECUTORY DELUSION 2 0.0008
300 DRUG TOLERANCE 4 0.0008
301 EXCORIATION 2 0.0008
302 HOSTILITY 2 0.0008
303 MYDRIASIS 10 0.0008
304 DELIRIUM 27 0.0008
305 PERIPHERAL VASCULAR DISORDER 4 0.0008
306 CARDIAC ARREST 64 0.0008
307 SINUS TACHYCARDIA 11 0.0008
308 TRISMUS 4 0.0008
309 TYPE 2 DIABETES MELLITUS 26 0.0008
310 APNOEA 6 0.0008
311 URINE OUTPUT INCREASED 2 0.0008
312 PRODUCT ADMINISTRATION INTERRUPTED 6 0.0008
313 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 2 0.0008
314 AFFECTIVE DISORDER 6 0.0008
315 RESPIRATORY ACIDOSIS 3 0.0008
316 TEMPOROMANDIBULAR JOINT SYNDROME 2 0.0007
317 ORGAN FAILURE 3 0.0007
318 BRADYPNOEA 2 0.0007
319 TACHYPNOEA 10 0.0007
320 AGORAPHOBIA 1 0.0007
321 SELF-MEDICATION 3 0.0007
322 PSYCHOMOTOR HYPERACTIVITY 12 0.0007
323 ACCIDENTAL EXPOSURE 3 0.0007
324 HEPATOMEGALY 7 0.0007
325 HYPOTONIA 7 0.0007
326 HEPATIC STEATOSIS 13 0.0007
327 RHABDOMYOLYSIS 29 0.0007
328 HALLUCINATION 52 0.0007
329 GASTROINTESTINAL NECROSIS 2 0.0007
330 AUTONOMIC NERVOUS SYSTEM IMBALANCE 2 0.0007
331 CARDIOMYOPATHY 10 0.0007
332 DISEASE RECURRENCE 32 0.0007
333 TENDERNESS 7 0.0007
334 CREPITATIONS 2 0.0007
335 INTENTIONAL DRUG MISUSE 14 0.0007
336 LOSS OF EMPLOYMENT 2 0.0007
337 ASTIGMATISM 1 0.0007
338 ACTIVITIES OF DAILY LIVING IMPAIRED 13 0.0007
339 BUNDLE BRANCH BLOCK RIGHT 3 0.0007
340 DRUG ABUSER 4 0.0007
341 FAMILY STRESS 2 0.0006
342 PRODUCT PRESCRIBING ISSUE 14 0.0006
343 HYPERGLYCAEMIA 23 0.0006
344 MIOSIS 5 0.0006
345 STUPOR 2 0.0006
346 BLOOD CHOLESTEROL INCREASED 29 0.0006
347 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2 0.0006
348 LYMPHOCYTE COUNT INCREASED 2 0.0006
349 REFUSAL OF TREATMENT BY PATIENT 4 0.0006
350 POLYURIA 5 0.0006
351 BRADYARRHYTHMIA 1 0.0006
352 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 2 0.0006
353 ANXIETY DISORDER 2 0.0006
354 LEFT VENTRICULAR DYSFUNCTION 4 0.0006
355 PLANTAR FASCIITIS 2 0.0006
356 DIABETIC RETINOPATHY 2 0.0006
357 MYOCLONUS 7 0.0006
358 PANCREATITIS 31 0.0006
359 BLOOD AMYLASE INCREASED 1 0.0006
360 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 6 0.0006
361 EYE MOVEMENT DISORDER 4 0.0006
362 DROOLING 4 0.0006
363 BLOOD CHLORIDE INCREASED 1 0.0006
364 HYPOPNOEA 2 0.0006
365 THROMBOPHLEBITIS 2 0.0006
366 ALOPECIA AREATA 1 0.0006
367 GLOSSITIS 2 0.0006
368 RESPIRATORY RATE INCREASED 5 0.0006
369 THIRST 10 0.0006
370 BRUXISM 3 0.0006
371 FACIAL BONES FRACTURE 2 0.0006
372 WITHDRAWAL SYNDROME 23 0.0005
373 PSYCHIATRIC SYMPTOM 4 0.0005
374 BLOOD PRESSURE DIASTOLIC DECREASED 4 0.0005
375 GRAND MAL CONVULSION 5 0.0005
376 VENTRICULAR FIBRILLATION 6 0.0005
377 BODY TEMPERATURE INCREASED 11 0.0005
378 AGRANULOCYTOSIS 10 0.0005
379 CARDIAC DYSFUNCTION 2 0.0005
380 BLOOD IRON INCREASED 1 0.0005
381 AUTOIMMUNE THYROIDITIS 2 0.0005
382 NEUTROPHILIA 3 0.0005
383 MYOCARDITIS 6 0.0005
384 LOW DENSITY LIPOPROTEIN INCREASED 4 0.0005
385 PANIC DISORDER 2 0.0005
386 NICOTINE DEPENDENCE 4 0.0005
387 EPIGASTRIC DISCOMFORT 2 0.0005
388 CYANOSIS 8 0.0005
389 DRUG SCREEN POSITIVE 4 0.0005
390 BLADDER DISORDER 5 0.0005
391 MOOD SWINGS 16 0.0005
392 CEREBRAL ATROPHY 2 0.0005
393 HYPERPHAGIA 2 0.0005
394 ANORECTAL DISORDER 1 0.0005
395 TREMOR 83 0.0005
396 RESTLESS LEGS SYNDROME 9 0.0005
397 RESTLESSNESS 18 0.0005
398 RESPIRATORY DEPRESSION 6 0.0005
399 INITIAL INSOMNIA 5 0.0005
400 HYPERTENSION 103 0.0005
401 ANAPHYLACTOID REACTION 2 0.0005
402 DRUG LEVEL INCREASED 8 0.0005
403 DRUG INEFFECTIVE 635 0.0005
404 PHOTOPHOBIA 9 0.0005
405 HAEMODIALYSIS 4 0.0005
406 HALLUCINATION, VISUAL 10 0.0005
407 INCONTINENCE 5 0.0005
408 SUDDEN DEATH 5 0.0005
409 SLEEP APNOEA SYNDROME 9 0.0005
410 SCREAMING 3 0.0005
411 LEFT VENTRICULAR HYPERTROPHY 2 0.0005
412 INCOHERENT 3 0.0005
413 DEPRESSION 105 0.0005
414 SOMNAMBULISM 3 0.0005
415 COLD SWEAT 8 0.0005
416 MENTAL IMPAIRMENT 11 0.0005
417 BACTERIAL TEST POSITIVE 1 0.0004
418 FEAR 12 0.0004
419 APPLICATION SITE URTICARIA 1 0.0004
420 MOOD ALTERED 12 0.0004
421 PANIC ATTACK 16 0.0004
422 NEOPLASM 5 0.0004
423 DRUG INTERACTION 69 0.0004
424 HYPOMAGNESAEMIA 6 0.0004
425 DISORIENTATION 17 0.0004
426 FEELING OF DESPAIR 2 0.0004
427 BILIRUBIN CONJUGATED INCREASED 1 0.0004
428 TREATMENT NONCOMPLIANCE 23 0.0004
429 SPEECH DISORDER 22 0.0004
430 HYPERLIPIDAEMIA 5 0.0004
431 TONGUE DISORDER 3 0.0004
432 BLOOD IMMUNOGLOBULIN E INCREASED 1 0.0004
433 EAR PAIN 8 0.0004
434 NO THERAPEUTIC RESPONSE 5 0.0004
435 HORMONE LEVEL ABNORMAL 2 0.0004
436 INSOMNIA 109 0.0004
437 HEPARIN-INDUCED THROMBOCYTOPENIA 2 0.0004
438 HYPERNATRAEMIA 2 0.0004
439 PRODUCT SUBSTITUTION ISSUE 23 0.0004
440 BRAIN INJURY 4 0.0004
441 HEART RATE IRREGULAR 9 0.0004
442 SOMNOLENCE 80 0.0004
443 INTENTIONAL SELF-INJURY 8 0.0004
444 ASPARTATE AMINOTRANSFERASE INCREASED 21 0.0004
445 HYPOTHERMIA 4 0.0004
446 RENAL FAILURE CHRONIC 3 0.0004
447 DISTURBANCE IN ATTENTION 21 0.0004
448 CACHEXIA 2 0.0004
449 AORTIC ARTERIOSCLEROSIS 1 0.0004
450 ATRIOVENTRICULAR BLOCK 3 0.0004
451 BENIGN PROSTATIC HYPERPLASIA 2 0.0004
452 FOETAL DEATH 2 0.0004
453 ANGER 13 0.0004
454 HYPERSOMNIA 11 0.0004
455 TACHYCARDIA 34 0.0004
456 FOOD CRAVING 2 0.0004
457 PULMONARY CONGESTION 5 0.0004
458 BREAST PAIN 4 0.0004
459 ALCOHOL POISONING 1 0.0004
460 ANXIETY 106 0.0004
461 DYSARTHRIA 14 0.0004
462 MUSCLE DISORDER 3 0.0004
463 JAW DISORDER 2 0.0004
464 FAECALOMA 2 0.0004
465 NONSPECIFIC REACTION 2 0.0004
466 INTENTIONAL OVERDOSE 23 0.0004
467 GYNAECOMASTIA 11 0.0004
468 COLECTOMY 2 0.0004
469 DEPRESSED LEVEL OF CONSCIOUSNESS 14 0.0004
470 ERECTILE DYSFUNCTION 9 0.0004
471 LETHARGY 20 0.0003
472 MUSCLE TWITCHING 8 0.0003
473 HYPERVENTILATION 2 0.0003
474 ADENOVIRUS INFECTION 1 0.0003
475 PRODUCT LABEL CONFUSION 2 0.0003
476 ABORTION 1 0.0003
477 MOVEMENT DISORDER 11 0.0003
478 ALANINE AMINOTRANSFERASE INCREASED 21 0.0003
479 DECREASED INTEREST 2 0.0003
480 DIABETES MELLITUS INADEQUATE CONTROL 6 0.0003
481 ATAXIA 4 0.0003
482 BRAIN HERNIATION 1 0.0003
483 ROAD TRAFFIC ACCIDENT 14 0.0003
484 ANAL INCONTINENCE 3 0.0003
485 CONVULSION 19 0.0003
486 OSTEOARTHRITIS 14 0.0003
487 VERTIGO 20 0.0003
488 DRUG DISPENSING ERROR 5 0.0003
489 HIP ARTHROPLASTY 5 0.0003
490 BLOOD THYROID STIMULATING HORMONE INCREASED 3 0.0003
491 CARDIOMEGALY 4 0.0003
492 PHARYNGEAL OEDEMA 5 0.0003
493 ABASIA 8 0.0003
494 SCOLIOSIS 2 0.0003
495 ILEUS 4 0.0003
496 PNEUMONIA ASPIRATION 8 0.0003
497 BLOOD CREATININE DECREASED 1 0.0003
498 LACERATION 3 0.0003
499 PRODUCT USE IN UNAPPROVED INDICATION 79 0.0003
500 BRAIN OEDEMA 4 0.0003
501 COMA 15 0.0003
502 ORAL PAIN 7 0.0003
503 HYPERHIDROSIS 40 0.0003
504 CARDIAC FLUTTER 2 0.0003
505 MUSCULOSKELETAL STIFFNESS 27 0.0003
506 BLOOD POTASSIUM INCREASED 5 0.0003
507 PHARYNGEAL SWELLING 3 0.0003
508 BRADYPHRENIA 2 0.0003
509 THERAPY CHANGE 3 0.0003
510 DYSGRAPHIA 2 0.0003
511 FEEDING DISORDER 6 0.0003
512 BLOOD TESTOSTERONE DECREASED 2 0.0003
513 OVERDOSE 63 0.0003
514 RESPIRATION ABNORMAL 2 0.0003
515 FORMICATION 2 0.0003
516 WHITE BLOOD CELL COUNT INCREASED 11 0.0003
517 DYSPHAGIA 27 0.0003
518 DIVERTICULUM 2 0.0003
519 APPENDICECTOMY 1 0.0003
520 POOR QUALITY SLEEP 6 0.0003
521 DECREASED ACTIVITY 3 0.0003
522 APPARENT DEATH 1 0.0003
523 LEUKOCYTOSIS 5 0.0003
524 HYPERTHYROIDISM 4 0.0003
525 SKIN LACERATION 3 0.0003
526 BLOOD PHOSPHORUS DECREASED 1 0.0003
527 CONFUSIONAL STATE 44 0.0003
528 ALCOHOL USE 1 0.0003
529 URINARY RETENTION 9 0.0003
530 HYPOGLYCAEMIA 13 0.0003
531 PAROSMIA 2 0.0003
532 ECONOMIC PROBLEM 4 0.0003
533 CHOLECYSTECTOMY 3 0.0003
534 HAEMODYNAMIC INSTABILITY 2 0.0003
535 MEMORY IMPAIRMENT 36 0.0003
536 EPILEPSY 8 0.0003
537 RENAL FAILURE ACUTE 11 0.0003
538 CONCUSSION 2 0.0003
539 HEART RATE DECREASED 9 0.0003
540 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
541 HEAD INJURY 8 0.0003
542 ULCER 4 0.0003
543 MACULAR DEGENERATION 3 0.0003
544 SCIATICA 4 0.0003
545 AZOTAEMIA 1 0.0003
546 LOSS OF CONSCIOUSNESS 32 0.0002
547 DRUG INTOLERANCE 24 0.0002
548 CRYING 9 0.0002
549 MYASTHENIA GRAVIS 2 0.0002
550 DRY MOUTH 20 0.0002
551 ASPHYXIA 2 0.0002
552 ENCEPHALOPATHY 6 0.0002
553 HYPERCALCAEMIA 3 0.0002
554 AORTIC DISSECTION 1 0.0002
555 ACUTE CORONARY SYNDROME 2 0.0002
556 LIVER FUNCTION TEST ABNORMAL 7 0.0002
557 DRUG WITHDRAWAL SYNDROME 21 0.0002
558 FEELING ABNORMAL 57 0.0002
559 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
560 RENAL DISORDER 11 0.0002
561 IMPAIRED WORK ABILITY 5 0.0002
562 ALCOHOLISM 1 0.0002
563 HEART RATE INCREASED 23 0.0002
564 MULTI-ORGAN FAILURE 4 0.0002
565 CARDIAC MURMUR 2 0.0002
566 ALTERED STATE OF CONSCIOUSNESS 5 0.0002
567 AMNESIA 15 0.0002
568 PLATELET COUNT INCREASED 3 0.0002
569 URINE OUTPUT DECREASED 2 0.0002
570 INTERVERTEBRAL DISC PROTRUSION 5 0.0002
571 AMENORRHOEA 4 0.0002
572 BLOOD CALCIUM INCREASED 2 0.0002
573 DEPRESSED MOOD 12 0.0002
574 SLEEP DISORDER 16 0.0002
575 BRADYCARDIA 12 0.0002
576 ACUTE RESPIRATORY DISTRESS SYNDROME 4 0.0002
577 QUALITY OF LIFE DECREASED 3 0.0002
578 SNEEZING 5 0.0002
579 PANCREATITIS ACUTE 5 0.0002
580 DEVELOPMENTAL DELAY 2 0.0002
581 ABDOMINAL HERNIA 1 0.0002
582 PERIPHERAL COLDNESS 3 0.0002
583 SHOCK 5 0.0002
584 DYSURIA 8 0.0002
585 LACTIC ACIDOSIS 7 0.0002
586 HUNGER 3 0.0002
587 COORDINATION ABNORMAL 3 0.0002
588 DISSEMINATED INTRAVASCULAR COAGULATION 3 0.0002
589 HEPATIC CIRRHOSIS 4 0.0002
590 ARTERIOSCLEROSIS 2 0.0002
591 INTESTINAL OBSTRUCTION 8 0.0002
592 UNEVALUABLE EVENT 16 0.0002
593 SPINAL DISORDER 2 0.0002
594 PRODUCT PACKAGING ISSUE 2 0.0002
595 SKIN DISORDER 7 0.0002
596 ACUTE RESPIRATORY FAILURE 4 0.0002
597 ATELECTASIS 2 0.0002
598 HERNIA 4 0.0002
599 DRUG EXPOSURE DURING PREGNANCY 7 0.0002
600 APATHY 3 0.0002
601 RENAL TUBULAR NECROSIS 2 0.0002
602 SWELLING 19 0.0002
603 URINARY INCONTINENCE 6 0.0002
604 INABILITY TO AFFORD MEDICATION 2 0.0002
605 ABDOMINAL TENDERNESS 1 0.0002
606 ANEURYSM 1 0.0002
607 ANAPHYLACTIC REACTION 11 0.0002
608 HYPOXIA 7 0.0002
609 NECK PAIN 11 0.0002
610 DRY THROAT 2 0.0002
611 SLUGGISHNESS 2 0.0002
612 AMMONIA INCREASED 1 0.0002
613 NEUTROPHIL COUNT INCREASED 2 0.0002
614 EAR DISCOMFORT 2 0.0002
615 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 5 0.0002
616 ANKLE FRACTURE 3 0.0002
617 UNRESPONSIVE TO STIMULI 5 0.0002
618 EJECTION FRACTION DECREASED 3 0.0002
619 EYE DISCHARGE 2 0.0002
620 RESPIRATORY FAILURE 14 0.0002
621 JOINT STIFFNESS 5 0.0002
622 BLOOD LACTIC ACID INCREASED 1 0.0002
623 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
624 METABOLIC ACIDOSIS 6 0.0002
625 INJURY 13 0.0002
626 BEHAVIOUR DISORDER 1 0.0002
627 OEDEMA 10 0.0002
628 ASPIRATION 2 0.0002
629 BLOOD GLUCOSE FLUCTUATION 2 0.0002
630 EYE DISORDER 6 0.0002
631 VENTRICULAR TACHYCARDIA 3 0.0002
632 AUTISM SPECTRUM DISORDER 1 0.0002
633 BLOOD PRESSURE DECREASED 12 0.0002
634 COAGULOPATHY 3 0.0002
635 HYPERTENSIVE CRISIS 2 0.0002
636 DEMENTIA 5 0.0002
637 WOUND 5 0.0002
638 ACUTE PULMONARY OEDEMA 1 0.0002
639 OCULAR DISCOMFORT 2 0.0002
640 EYE PAIN 10 0.0002
641 REBOUND EFFECT 2 0.0002
642 MYOCARDIAL ISCHAEMIA 2 0.0002
643 BRONCHITIS 13 0.0002
644 NIGHTMARE 6 0.0002
645 ELECTROLYTE IMBALANCE 2 0.0002
646 EYELID OEDEMA 2 0.0002
647 POST PROCEDURAL HAEMORRHAGE 2 0.0002
648 DYSSTASIA 5 0.0002
649 RHINORRHOEA 11 0.0002
650 HYPOTENSION 34 0.0002
651 LABORATORY TEST ABNORMAL 5 0.0002
652 BLOOD IRON DECREASED 2 0.0002
653 BLOOD CREATININE INCREASED 11 0.0002
654 POLLAKIURIA 7 0.0002
655 MUSCULAR WEAKNESS 19 0.0002
656 WRIST FRACTURE 2 0.0002
657 HEPATIC FAILURE 5 0.0002
658 HEPATITIS C 2 0.0002
659 APHASIA 5 0.0002
660 DRUG EFFECT INCOMPLETE 6 0.0002
661 NEURALGIA 4 0.0002
662 SPINAL OPERATION 2 0.0002
663 PHARYNGITIS 2 0.0002
664 MIDDLE INSOMNIA 3 0.0002
665 OXYGEN SATURATION DECREASED 9 0.0002
666 SWOLLEN TONGUE 5 0.0002
667 SYNCOPE 16 0.0002
668 HYPONATRAEMIA 9 0.0002
669 DIZZINESS 79 0.0002
670 BLOOD PRESSURE INCREASED 24 0.0002
671 GAIT DISTURBANCE 30 0.0002
672 HYPOPHAGIA 4 0.0002
673 PULMONARY OEDEMA 7 0.0002
674 POST PROCEDURAL COMPLICATION 3 0.0002
675 THERAPEUTIC RESPONSE UNEXPECTED 7 0.0002
676 ROTATOR CUFF SYNDROME 2 0.0002
677 DRUG RESISTANCE 4 0.0002
678 RASH GENERALISED 4 0.0002
679 DIPLOPIA 4 0.0002
680 ANGINA UNSTABLE 1 0.0002
681 NEPHROLITHIASIS 7 0.0002
682 ANHEDONIA 4 0.0002
683 BEDRIDDEN 2 0.0002
684 TOOTH INFECTION 2 0.0002
685 DISABILITY 3 0.0002
686 CONSTIPATION 33 0.0002
687 SOPOR 2 0.0002
688 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
689 FUNGAL INFECTION 5 0.0001
690 PREGNANCY 3 0.0001
691 ABORTION SPONTANEOUS 6 0.0001
692 GAIT INABILITY 5 0.0001
693 JOINT RANGE OF MOTION DECREASED 2 0.0001
694 PRODUCT USE ISSUE 28 0.0001
695 THERAPEUTIC RESPONSE DECREASED 9 0.0001
696 ARRHYTHMIA 7 0.0001
697 PRODUCT TASTE ABNORMAL 2 0.0001
698 SEIZURE 17 0.0001
699 ACUTE HEPATIC FAILURE 2 0.0001
700 MATERNAL EXPOSURE DURING PREGNANCY 13 0.0001
701 CORONARY ARTERY OCCLUSION 2 0.0001
702 GASTRIC DISORDER 5 0.0001
703 CHILLS 17 0.0001
704 ABNORMAL DREAMS 4 0.0001
705 TOOTH LOSS 3 0.0001
706 INTERSTITIAL LUNG DISEASE 7 0.0001
707 DRUG ABUSE 12 0.0001
708 BLISTER 8 0.0001
709 DIALYSIS 2 0.0001
710 EATING DISORDER 3 0.0001
711 NEUTROPENIA 19 0.0001
712 PARALYSIS 2 0.0001
713 SUBDURAL HAEMATOMA 2 0.0001
714 ANGINA PECTORIS 4 0.0001
715 CARDIAC DISORDER 13 0.0001
716 VISION BLURRED 19 0.0001
717 HYPOKINESIA 2 0.0001
718 WRONG TECHNIQUE IN DRUG USAGE PROCESS 5 0.0001
719 FLUID OVERLOAD 2 0.0001
720 VISUAL IMPAIRMENT 17 0.0001
721 GASTROENTERITIS 2 0.0001
722 PULMONARY EMBOLISM 13 0.0001
723 LIVER DISORDER 6 0.0001
724 ARTHROPOD BITE 1 0.0001
725 SKIN HAEMORRHAGE 2 0.0001
726 WHEEZING 8 0.0001
727 EYE SWELLING 5 0.0001
728 PULMONARY MASS 2 0.0001
729 IMMUNODEFICIENCY 2 0.0001
730 GLOSSODYNIA 3 0.0001
731 HYPOAESTHESIA 20 0.0001
732 THERAPY NON-RESPONDER 6 0.0001
733 FALL 44 0.0001
734 OSTEOPENIA 2 0.0001
735 FEELING HOT 8 0.0001
736 HYPOKALAEMIA 6 0.0001
737 EMOTIONAL DISORDER 4 0.0001
738 CHEST PAIN 24 0.0001
739 MUSCULOSKELETAL CHEST PAIN 2 0.0001
740 BACK PAIN 30 0.0001
741 MENINGIOMA 2 0.0001
742 BRAIN FOG 2 0.0001
743 MUSCLE SPASMS 23 0.0001
744 BLOOD PRESSURE FLUCTUATION 3 0.0001
745 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 6 0.0001
746 CONTUSION 12 0.0001
747 NIGHT SWEATS 4 0.0001
748 MUSCLE TIGHTNESS 2 0.0001
749 BACK DISORDER 2 0.0001
750 DYSPEPSIA 12 0.0001
751 VISUAL ACUITY REDUCED 4 0.0001
752 BLOOD UREA INCREASED 2 0.0001
753 CELLULITIS 6 0.0001
754 PERICARDITIS 2 0.0001
755 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
756 OROPHARYNGEAL PAIN 11 0.0001
757 CARDIOVASCULAR DISORDER 3 0.0001
758 CATARACT 7 0.0001
759 VOMITING 55 0.0001
760 HAEMATURIA 4 0.0001
761 HEADACHE 73 0.0001
762 BLOOD MAGNESIUM DECREASED 1 0.0001
763 ABDOMINAL DISTENSION 12 0.0001
764 ORTHOSTATIC HYPOTENSION 2 0.0001
765 INTENTIONAL PRODUCT MISUSE 10 0.0001
766 NAUSEA 90 0.0001
767 DRUG ERUPTION 2 0.0001
768 GALLBLADDER DISORDER 2 0.0001
769 GOUT 2 0.0001
770 DRUG EFFECT DECREASED 6 0.0001
771 PALPITATIONS 13 0.0001
772 THROAT TIGHTNESS 3 0.0001
773 GASTROENTERITIS VIRAL 2 0.0001
774 TOOTHACHE 2 0.0001
775 LIMB INJURY 3 0.0001
776 PALLOR 3 0.0001
777 DYSPNOEA 62 0.0001
778 ACCIDENTAL OVERDOSE 4 0.0001
779 FEELING COLD 3 0.0001
780 SEPSIS 12 0.0001
781 PRODUCT DOSE OMISSION 7 0.0001
782 APPENDICITIS 1 0.0001
783 HYPOCALCAEMIA 2 0.0001
784 COLITIS 4 0.0001
785 FOOT FRACTURE 2 0.0001
786 INTENTIONAL DOSE OMISSION 3 0.0001
787 FEELING JITTERY 2 0.0001
788 LOWER LIMB FRACTURE 2 0.0001
789 AFFECT LABILITY 1 0.0001
790 GLAUCOMA 2 0.0001
791 ATRIAL FIBRILLATION 10 0.0001
792 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
793 CHOKING 2 0.0001
794 ORAL HERPES 2 0.0001
795 BONE PAIN 6 0.0001
796 NASAL CONGESTION 6 0.0001
797 ABDOMINAL DISCOMFORT 17 0.0001
798 SINUS DISORDER 2 0.0001
799 HAEMATOCRIT DECREASED 2 0.0001
800 OFF LABEL USE 88 0.0001
801 RESPIRATORY DISORDER 3 0.0001
802 SPINAL FRACTURE 2 0.0001
803 URINARY TRACT INFECTION 17 0.0001
804 GASTROOESOPHAGEAL REFLUX DISEASE 8 0.0001
805 LACRIMATION INCREASED 3 0.0001
806 PRODUCT PHYSICAL ISSUE 2 0.0001
807 PRODUCT ADMINISTRATION ERROR 2 0.0001
808 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 20 0.0001
809 OEDEMA PERIPHERAL 12 0.0001
810 BONE MARROW FAILURE 2 0.0001
811 FLUSHING 10 0.0001
812 ADVERSE EVENT 9 0.0001
813 DEHYDRATION 13 0.0001
814 PRODUCT PREPARATION ERROR 2 0.0001
815 INJECTION SITE WARMTH 2 0.0001
816 RIB FRACTURE 2 0.0001
817 PULMONARY HYPERTENSION 2 0.0001
818 NERVOUSNESS 5 0.0001
819 PAIN 58 0.0001
820 CYSTITIS 3 0.0001
821 HYPOTHYROIDISM 3 0.0001
822 JOINT INJURY 2 0.0001
823 BODY HEIGHT DECREASED 1 0.0001
824 PRURITUS GENERALISED 2 0.0001
825 ABDOMINAL PAIN UPPER 19 0.0001
826 WHITE BLOOD CELL COUNT DECREASED 10 0.0001
827 CHRONIC KIDNEY DISEASE 7 0.0001
828 BACK INJURY 1 0.0001
829 HYPERSENSITIVITY 17 0.0001
830 INTENTIONAL PRODUCT USE ISSUE 8 0.0001
831 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 5 0.0001
832 STAPHYLOCOCCAL INFECTION 3 0.0001
833 HAEMATOCHEZIA 5 0.0001
834 ANGIOEDEMA 4 0.0001
835 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
836 TRANSAMINASES INCREASED 2 0.0001
837 ARTHRITIS 7 0.0001
838 BLOOD CALCIUM DECREASED 1 0.0001
839 MALAISE 39 0.0001
840 TRANSIENT ISCHAEMIC ATTACK 3 0.0001
841 CHROMATURIA 2 0.0001
842 FLATULENCE 5 0.0001
843 PRODUCT AVAILABILITY ISSUE 2 0.0001
844 CARDIAC FAILURE CONGESTIVE 7 0.0001
845 DRUG DEPENDENCE 14 0.0001
846 THROMBOSIS 7 0.0001
847 UPPER RESPIRATORY TRACT INFECTION 4 0.0001
848 PERICARDIAL EFFUSION 2 0.0001
849 DECREASED APPETITE 20 0.0001
850 ABDOMINAL PAIN 20 0.0001
851 RASH MACULAR 3 0.0001
852 INFLUENZA LIKE ILLNESS 7 0.0001
853 ACUTE KIDNEY INJURY 13 0.0001
854 LYMPHADENOPATHY 3 0.0001
855 BACTERAEMIA 1 0.0001
856 MIGRAINE 8 0.0001
857 ACCIDENT 1 0.0001
858 MOBILITY DECREASED 6 0.0001
859 INCORRECT DOSE ADMINISTERED 19 0.0001
860 INFECTION 12 0.0001
861 EMOTIONAL DISTRESS 10 0.0001
862 C-REACTIVE PROTEIN INCREASED 3 0.0001
863 FATIGUE 64 0.0001
864 LIVER INJURY 2 0.0001
865 PAIN IN EXTREMITY 24 0.0001
866 ABNORMAL WEIGHT GAIN 1 0.0001
867 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
868 EXPOSURE DURING PREGNANCY 5 0.0001
869 APPLICATION SITE IRRITATION 1 0.0001
870 RHEUMATOID ARTHRITIS 9 0.0001
871 HAEMATEMESIS 2 0.0001
872 WEIGHT DECREASED 22 0.0001
873 SKIN ULCER 2 0.0001
874 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 4 0.0001
875 HAEMORRHAGE 8 0.0001
876 PARAESTHESIA 12 0.0001
877 GASTRITIS 2 0.0001
878 ANKYLOSING SPONDYLITIS 1 0.0001
879 ADVERSE REACTION 1 0.0001
880 RENAL FAILURE 10 0.0001
881 MENSTRUATION IRREGULAR 2 0.0001
882 ASTHENIA 28 0.0001
883 JAUNDICE 2 0.0001
884 PNEUMONIA 24 0.0001
885 FOETAL EXPOSURE DURING PREGNANCY 6 0.0001
886 PRODUCT QUALITY ISSUE 10 0.0001
887 NEUTROPHIL COUNT DECREASED 3 0.0001
888 RASH 32 0.0001
889 HEPATIC ENZYME INCREASED 5 0.0001
890 OSTEOPOROSIS 3 0.0001
891 RESPIRATORY DISTRESS 2 0.0001
892 ARTHROPATHY 4 0.0001
893 HAEMOPTYSIS 2 0.0001
894 BLOOD TEST ABNORMAL 1 0.0001
895 MYALGIA 12 0.0001
896 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 5 0.0001
897 RED BLOOD CELL COUNT DECREASED 2 0.0001
898 BALANCE DISORDER 6 0.0001
899 GENERAL PHYSICAL HEALTH DETERIORATION 8 0.0001
900 SEPTIC SHOCK 3 0.0001
901 HAEMOGLOBIN DECREASED 7 0.0001
902 ERYTHEMA 14 0.0001
903 GASTROINTESTINAL DISORDER 6 0.0001
904 BONE LOSS 1 0.0001
905 BLOOD POTASSIUM DECREASED 2 0.0001
906 PYREXIA 23 0.0001
907 PREMATURE BABY 2 0.0001
908 BLOOD COUNT ABNORMAL 1 0.0001
909 ACNE 5 0.0001
910 ILL-DEFINED DISORDER 4 0.0001
911 PLEURAL EFFUSION 4 0.0001
912 SKIN DISCOLOURATION 3 0.0001
913 NERVOUS SYSTEM DISORDER 2 0.0001
914 DRUG-INDUCED LIVER INJURY 2 0.0001
915 OCULAR HYPERAEMIA 3 0.0001
916 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
917 NEUROPATHY PERIPHERAL 6 0.0001
918 MYOCARDIAL INFARCTION 11 0.0001
919 PRODUCTIVE COUGH 3 0.0001
920 RASH ERYTHEMATOUS 3 0.0001
921 BLOOD GLUCOSE DECREASED 3 0.0001
922 SWELLING FACE 4 0.0001
923 CHOLELITHIASIS 2 0.0001
924 DRY EYE 3 0.0001
925 VIRAL INFECTION 2 0.0001
926 LIP SWELLING 2 0.0001
927 DEATH 51 0.0001
928 PRODUCT DOSE OMISSION ISSUE 17 0.0001
929 ARTHRALGIA 24 0.0001
930 COUGH 16 0.0001
931 BURNING SENSATION 4 0.0001
932 DERMATITIS ATOPIC 3 0.0001
933 PLATELET COUNT DECREASED 6 0.0001
934 INCORRECT ROUTE OF DRUG ADMINISTRATION 2 0.0001
935 DIARRHOEA 36 0.0001
936 RASH PRURITIC 3 0.0001
937 BACTERIAL INFECTION 1 0.0001
938 HEPATIC FUNCTION ABNORMAL 2 0.0001
939 BLOOD SODIUM DECREASED 1 0.0001
940 BLOOD URINE PRESENT 1 0.0001
941 EYE IRRITATION 3 0.0001
942 NO ADVERSE EVENT 9 0.0000
943 DISCOMFORT 3 0.0000
944 CHEST DISCOMFORT 5 0.0000
945 ILLNESS 5 0.0000
946 DRUG DOSE OMISSION 8 0.0000
947 GASTROINTESTINAL HAEMORRHAGE 4 0.0000
948 HYPOACUSIS 2 0.0000
949 VAGINAL HAEMORRHAGE 2 0.0000
950 PERIPHERAL SWELLING 7 0.0000
951 APPLICATION SITE PAIN 1 0.0000
952 THROMBOCYTOPENIA 5 0.0000
953 PRURITUS 17 0.0000
954 MULTIPLE SCLEROSIS RELAPSE 3 0.0000
955 TINNITUS 2 0.0000
956 MULTIPLE SCLEROSIS 2 0.0000
957 JOINT SWELLING 5 0.0000
958 CEREBROVASCULAR ACCIDENT 7 0.0000
959 ALOPECIA 8 0.0000
960 DYSGEUSIA 3 0.0000
961 HOT FLUSH 3 0.0000
962 HOSPITALISATION 6 0.0000
963 THERAPY CESSATION 2 0.0000
964 INFLAMMATION 2 0.0000
965 APPLICATION SITE ERYTHEMA 1 0.0000
966 DRY SKIN 5 0.0000
967 BLOOD BILIRUBIN INCREASED 1 0.0000
968 ANAEMIA 7 0.0000
969 MEDICATION ERROR 2 0.0000
970 URTICARIA 6 0.0000
971 ASTHMA 4 0.0000
972 HERPES ZOSTER 2 0.0000
973 DYSPHONIA 2 0.0000
974 ASCITES 1 0.0000
975 ACUTE MYOCARDIAL INFARCTION 1 0.0000
976 DISEASE PROGRESSION 4 0.0000
977 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 6 0.0000
978 STOMATITIS 2 0.0000
979 INJECTION SITE ERYTHEMA 4 0.0000
980 BONE DENSITY DECREASED 1 0.0000
981 DEEP VEIN THROMBOSIS 2 0.0000
982 PSORIASIS 4 0.0000
983 INFUSION RELATED REACTION 2 0.0000
984 NASOPHARYNGITIS 5 0.0000
985 INFLUENZA 3 0.0000
986 INJECTION SITE SWELLING 2 0.0000
987 BLINDNESS 1 0.0000
988 SKIN EXFOLIATION 2 0.0000
989 INJECTION SITE PAIN 7 0.0000
990 COVID-19 4 0.0000
991 BLADDER CANCER 1 0.0000
992 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000